TNFRSF10B and cancer: SKR has a significantly negative effect on cancer cells, induces apoptosis, upregulates DR5 in normoxic as well as hypoxic conditions without an effect on pathologically unchanged healthy cells and reverses TRAIL resistance in hypoxia as well as in TRAIL-resistant cell lines.